Chris Cain
Papers
1
Total Citations
13
H-Index
1
About
Chris Cain is a leading figure in the advancement of endovascular therapy, with a focused expertise in robotic-assisted peripheral vascular intervention (PVI). His primary research has centered on demonstrating the feasibility and safety of robotic platforms for treating peripheral artery disease (PAD), specifically targeting challenging femoropopliteal lesions. Cain’s major contribution is the seminal RAPID II study, which provided critical evidence that robotic PVI using drug-coated balloons is not only technically feasible but also significantly reduces operator radiation exposure—a key occupational hazard for interventionalists. This work, which has garnered 13 citations, represents a pivotal step toward integrating precision robotics into standard PVI practice, potentially enhancing procedural accuracy and physician safety. By quantifying the dual benefits of clinical efficacy and reduced radiation risk, Cain’s research is helping to shape a future where complex peripheral interventions are performed with greater control and lower physical toll on the operator. His findings are essential reading for researchers and clinicians exploring the intersection of robotics and vascular medicine.
Research Focus
Key Achievements
Top Papers
- 1